{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:43:59Z","timestamp":1768254239030,"version":"3.49.0"},"reference-count":33,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National High Level Hospital","award":["PUMCH-A-210"],"award-info":[{"award-number":["PUMCH-A-210"]}]},{"name":"National High Level Hospital","award":["PUMCH-B-041"],"award-info":[{"award-number":["PUMCH-B-041"]}]},{"name":"National High Level Hospital","award":["PUMCH-C-025"],"award-info":[{"award-number":["PUMCH-C-025"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,6,27]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Keloids, benign fibroproliferative tumours characterised by excessive fibroblast proliferation and over-deposition of extracellular matrix, pose a therapeutic challenge with high recurrence rates. Betamethasone (diprospan) injection (BI) is one of the most common non-invasive therapies for keloids. Pulsed dye laser (PDL) has the function of closing microvessels, which may become one of the auxiliary treatment methods of BI and may enhance its curative effect. Some studies suggest that the combination of a dual-wavelength dye laser (DWL) and BI may offer superior efficacy. This randomised controlled trial aims to evaluate whether the combined therapy of DWL+BI outperforms BI alone in treating keloids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This single-centre, parallel positive control, randomised trial evaluates the efficacy and safety of DWL (585\u2009nm PDL+1064\u2009nm neodymium-doped yttrium aluminium garnet) combined with BI for keloid treatment. Enrolling 66 adult patients, participants are randomised into DWL+BI\u2009or BI groups in a 1:1 ratio. Over 12 weeks, each group undergoes four treatment sessions, ensuring blinding for outcome assessors. Data collection occurs at multiple time points (4, 12, 24 and 52 weeks), with primary outcomes assessing the Vancouver Scar Scale (VSS) improvement rate 24 weeks after the last intervention. Secondary outcomes include VSS improvement rates, changes in keloid volume, changes in relative perfusion index measured by laser speckle contrast imaging, Patient and Observer Scar Assessment Scale results and patient satisfaction. Safety assessments include vital signs, laboratory tests, pregnancy tests and self-reports of adverse reactions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The results will be presented in peer-reviewed journals and at international conferences. This study is approved by the Ethics Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>Chinese Clinical Trial Register (ChiCTR2400080148).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-084939","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:22:48Z","timestamp":1720585368000},"page":"e084939","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Dual-wavelength dye laser combined with betamethasone injection for treatment of keloids: protocol of a randomised controlled trial"],"prefix":"10.1136","volume":"14","author":[{"given":"Junxian","family":"Wen","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weida","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanze","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China"},{"name":"Department of International Medical Service, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3043-0020","authenticated-orcid":false,"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,7,9]]},"reference":[{"key":"2025121407541422000_14.7.e084939.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2016.01.013"},{"key":"2025121407541422000_14.7.e084939.2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01810","article-title":"Understanding Keloid Pathobiology from a quasi-neoplastic perspective: less of a scar and more of a chronic inflammatory disease with cancer-like tendencies","volume":"10","author":"Tan","year":"2019","journal-title":"Front Immunol"},{"key":"2025121407541422000_14.7.e084939.3","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00403-023-02535-3","article-title":"Treatment of traumatic hypertrophic scars and Keloids: a systematic review of randomized control trials","volume":"315","author":"Worley","year":"2023","journal-title":"Arch Dermatol Res"},{"key":"2025121407541422000_14.7.e084939.4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ced.14920","article-title":"Novel targets and therapies for Keloid","volume":"47","author":"Naik","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"2025121407541422000_14.7.e084939.5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/ijd.15159","article-title":"Keloids: a review of therapeutic management","volume":"60","author":"Ekstein","year":"2021","journal-title":"Int J Dermatol"},{"key":"2025121407541422000_14.7.e084939.6","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-023-02192-7","article-title":"Keloid treatments: an evidence-based systematic review of recent advances","volume":"12","author":"Walsh","year":"2023","journal-title":"Syst Rev"},{"key":"2025121407541422000_14.7.e084939.7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/14764172.2015.1114648","article-title":"Pulsed dye laser versus long-pulsed nd:YAG laser in the treatment of hypertrophic scars and Keloid: a comparative randomized split-scar trial","volume":"18","author":"Al-Mohamady","year":"2016","journal-title":"J Cosmet Laser Ther"},{"key":"2025121407541422000_14.7.e084939.8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/JCAS.JCAS_136_16","article-title":"Fractional carbon dioxide, long pulse nd:YAG and pulsed dye laser in the management of Keloids","volume":"10","author":"Annabathula","year":"2017","journal-title":"J Cutan Aesthet Surg"},{"key":"2025121407541422000_14.7.e084939.9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/09546634.2019.1610550","article-title":"Combination of pulsed dye laser and verapamil in comparison with verapamil alone in the treatment of Keloid","volume":"31","author":"Khattab","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"2025121407541422000_14.7.e084939.10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-3-030-44766-3_31","volume-title":"Textbook on Scar Management: State of the Art Management and Emerging Technologies","volume":"2020","author":"Nischwitz","year":"2020"},{"key":"2025121407541422000_14.7.e084939.11","doi-asserted-by":"crossref","DOI":"10.34172\/jlms.2023.30","article-title":"Combination of fractional er:YAG laser, pulsed dye laser, and Intralesional triamcinolone with 5-fluorouracil for Keloid treatment","volume":"14","author":"Anggawirya","year":"2023","journal-title":"J Lasers Med Sci"},{"key":"2025121407541422000_14.7.e084939.12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14122738","article-title":"Laser-assisted drug delivery: a systematic review of safety and adverse events","volume":"14","author":"Ng","year":"2022","journal-title":"Pharmaceutics"},{"key":"2025121407541422000_14.7.e084939.13","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3182a8070c"},{"key":"2025121407541422000_14.7.e084939.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025121407541422000_14.7.e084939.15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/PRS.0000000000000415","article-title":"High-dose-rate Brachytherapy for the treatment of recalcitrant Keloids: a unique, effective treatment protocol","volume":"134","author":"van Leeuwen","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"2025121407541422000_14.7.e084939.16","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-14-439","article-title":"Intralesional Cryotherapy versus Excision and corticosteroids or Brachytherapy for Keloid treatment: study protocol for a randomised controlled trial","volume":"14","author":"Bijlard","year":"2013","journal-title":"Trials"},{"key":"2025121407541422000_14.7.e084939.17","doi-asserted-by":"publisher","DOI":"10.1097\/BCR.0b013e318239f5dd"},{"key":"2025121407541422000_14.7.e084939.18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/PRS.0000000000006069","article-title":"Early postoperative application of botulinum toxin type A prevents hypertrophic scarring after epicanthoplasty: a split-face, double-blind","volume":"144","author":"Huang","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"2025121407541422000_14.7.e084939.19","doi-asserted-by":"publisher","DOI":"10.1097\/01.PRS.0000122207.28773.56"},{"key":"2025121407541422000_14.7.e084939.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2010.05.012"},{"key":"2025121407541422000_14.7.e084939.21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/lsm.22470","article-title":"Increased blood flow in Keloids and adjacent skin revealed by laser speckle contrast imaging","volume":"48","author":"Liu","year":"2016","journal-title":"Lasers Surg Med"},{"key":"2025121407541422000_14.7.e084939.22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/lsm.23331","article-title":"Heterogeneous features of Keloids assessed by laser speckle contrast imaging: a cross-sectional study","volume":"53","author":"Chen","year":"2021","journal-title":"Lasers Surg Med"},{"key":"2025121407541422000_14.7.e084939.23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/lsm.23579","article-title":"Relative perfusion index: an objective, quantitative and noninvasive method for evaluating the severity of Keloids","volume":"54","author":"Li","year":"2022","journal-title":"Lasers Surg Med"},{"key":"2025121407541422000_14.7.e084939.24","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1097\/DSS.0000000000002836","article-title":"Laser speckle contrast imaging for the objective assessment of blood perfusion in Keloids treated with dual-wavelength laser therapy","volume":"47","author":"Xu","year":"2021","journal-title":"Dermatol Surg"},{"key":"2025121407541422000_14.7.e084939.25","article-title":"Laser therapy for treating hypertrophic and Keloid scars","volume":"9","author":"Leszczynski","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121407541422000_14.7.e084939.26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/wound.2018.0798","article-title":"Comparison of fractional CO(2) laser, verapamil, and triamcinolone for the treatment of Keloid","volume":"8","author":"Srivastava","year":"2019","journal-title":"Adv Wound Care"},{"key":"2025121407541422000_14.7.e084939.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01214-0","article-title":"Characterization of the skin Keloid Microenvironment","volume":"21","author":"Zhang","year":"2023","journal-title":"Cell Commun Signal"},{"key":"2025121407541422000_14.7.e084939.28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40257-022-00744-6","article-title":"Hypertrophic scars and Keloids: advances in treatment and review of established therapies","volume":"24","author":"Frech","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"2025121407541422000_14.7.e084939.29","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S133672"},{"key":"2025121407541422000_14.7.e084939.30","doi-asserted-by":"crossref","first-page":"79e","DOI":"10.1097\/PRS.0000000000008667","article-title":"The most current Algorithms for the treatment and prevention of hypertrophic scars and Keloids: A 2020 update of the Algorithms published 10 years ago","volume":"149","author":"Ogawa","year":"2022","journal-title":"Plast Reconstr Surg"},{"key":"2025121407541422000_14.7.e084939.31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1586\/erd.12.56","article-title":"Pulsed dye laser for the treatment of Keloid and hypertrophic scars: a systematic review","volume":"9","author":"de las Alas","year":"2012","journal-title":"Expert Rev Med Devices"},{"key":"2025121407541422000_14.7.e084939.32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jdv.14490","article-title":"Safety and efficacy of dual-wavelength laser (1064 + 595 nM) for treatment of non-treated port-wine stains","volume":"32","author":"Wang","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2025121407541422000_14.7.e084939.33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/jocd.13068","article-title":"Treatment of Acne Scarring with a novel dual-wavelength laser","volume":"18","author":"Gold","year":"2019","journal-title":"J Cosmet Dermatol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-084939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:54:25Z","timestamp":1765727665000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-084939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7,9]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/bmjopen-2024-084939"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-084939","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}